Protagonist Therapeutics, Inc ($PTGX)
Filing Information
| Accession Number | 0001104659-26-058860 |
|---|---|
| Form Type | 4 |
| Filing Date | May 12, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
131,130
Total Value
$6,157,440.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 7, 2026 | Exercise/Conversion | 24,000 | $6.45 | $154,800.00 | 31,825 | Direct | โ | View Details | |
Director | Common Stock | โ | May 7, 2026 | Exercise/Conversion | 12,000 | $6.98 | $83,760.00 | 43,825 | Direct | โ | View Details | |
Director | Common Stock | โ | May 7, 2026 | Sale | 36,000 | $100.14 | $3,605,040.00 | 27,825 | Direct | โ | View Details | |
Director | Common Stock | โ | May 7, 2026 | Sale | 12,000 | $100.07 | $1,200,840.00 | 6,000 | Indirect | By Bryan & Courtney Giraudo Trust | View Details | |
Director | Common Stock | โ | May 8, 2026 | Sale | 6,000 | $100.00 | $600,000.00 | 0 | Indirect | By Bryan & Courtney Giraudo Trust | View Details | |
Director | Common Stock | โ | May 8, 2026 | Sale | 5,130 | $100.00 | $513,000.00 | 12,695 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | May 7, 2026 | Exercise/Conversion | 24,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | May 7, 2026 | Exercise/Conversion | 12,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |